Carl E. Allen

15.2k total citations · 3 hit papers
147 papers, 6.2k citations indexed

About

Carl E. Allen is a scholar working on Physiology, Immunology and Infectious Diseases. According to data from OpenAlex, Carl E. Allen has authored 147 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Physiology, 54 papers in Immunology and 40 papers in Infectious Diseases. Recurrent topics in Carl E. Allen's work include Histiocytic Disorders and Treatments (58 papers), Parvovirus B19 Infection Studies (37 papers) and Autoimmune and Inflammatory Disorders Research (34 papers). Carl E. Allen is often cited by papers focused on Histiocytic Disorders and Treatments (58 papers), Parvovirus B19 Infection Studies (37 papers) and Autoimmune and Inflammatory Disorders Research (34 papers). Carl E. Allen collaborates with scholars based in United States, United Kingdom and Canada. Carl E. Allen's co-authors include Kenneth L. McClain, Michael B. Jordan, Sheila Weitzman, Miriam Mérad, Alexandra H. Filipovich, Claudia A. Kozinetz, Carlos Rodríguez‐Galindo, Xiaoying Yu, Stephan Ladisch and Marie‐Luise Berres and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Carl E. Allen

138 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How I treat hemophagocytic lymphohistiocytosis

2011 767 citations Carl E. Allen, Kenneth L. McClain et al. Blood profile →
Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

2018 313 citations Carlos Rodríguez‐Galindo, Carl E. Allen et al. Blood profile →
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

2020 311 citations Carl E. Allen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl E. Allen United States	40	2.8k	2.6k	2.4k	2.4k	1.2k	147	6.2k
Stephan Ladisch United States	37	3.8k 1.3×	4.8k 1.8×	4.0k 1.6×	2.0k 0.8×	1.5k 1.3×	74	8.8k
Jean Donadieu France	49	2.0k 0.7×	914 0.3×	2.2k 0.9×	3.6k 1.5×	1.6k 1.3×	201	7.3k
Ulrike Pötschger Austria	37	1.2k 0.4×	1.1k 0.4×	523 0.2×	1.6k 0.7×	1.2k 1.0×	99	5.3k
Gritta Janka Germany	50	6.8k 2.4×	10.7k 4.1×	7.3k 3.0×	1.0k 0.4×	1.4k 1.2×	139	12.9k
David Webb United Kingdom	32	2.7k 1.0×	5.7k 2.2×	3.1k 1.3×	362 0.2×	635 0.5×	71	7.6k
Marc Michel France	49	449 0.2×	6.2k 2.3×	1.6k 0.7×	1.2k 0.5×	931 0.8×	279	8.3k
Paul Coppo France	42	1.2k 0.4×	4.0k 1.5×	5.6k 2.3×	227 0.1×	428 0.4×	248	7.9k
Christina Peters Austria	48	531 0.2×	4.1k 1.5×	1.2k 0.5×	637 0.3×	450 0.4×	242	8.2k
Paul Veys United Kingdom	52	748 0.3×	3.5k 1.3×	3.0k 1.2×	443 0.2×	456 0.4×	186	7.7k
Antonio M. Risitano Italy	48	729 0.3×	3.5k 1.3×	5.6k 2.3×	428 0.2×	206 0.2×	200	8.1k

Countries citing papers authored by Carl E. Allen

Since Specialization

Citations

This map shows the geographic impact of Carl E. Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl E. Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl E. Allen more than expected).

Fields of papers citing papers by Carl E. Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl E. Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl E. Allen. The network helps show where Carl E. Allen may publish in the future.

Co-authorship network of co-authors of Carl E. Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Carl E. Allen. A scholar is included among the top collaborators of Carl E. Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl E. Allen. Carl E. Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCarthy, Kathleen, Nilesh Desai, Stacie Peacock Shepherd, et al.. (2025). Sustained Response to Pan-BRAF Inhibitor Plixorafenib (FORE8394, PLX8394) in a Young Adult With Neurodegenerative Langerhans Cell Histiocytosis. JCO Precision Oncology. 9(9). e2500225–e2500225.

Wistinghausen, Birte, Donald A. Barkauskas, Lauren Saguilig, et al.. (2024). Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study. Blood Advances. 8(5). 1116–1127. 6 indexed citations

Makras, Polyzois, Dana Erickson, Caroline Davidge‐Pitts, et al.. (2024). Approach to the Patient: From Endocrinopathy to the Diagnosis of a Histiocytic Disorder. The Journal of Clinical Endocrinology & Metabolism. 110(6). 1756–1766. 3 indexed citations

Caro‐Vegas, Carolina, Alice Peng, Allison Silverstein, et al.. (2023). Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. JCI Insight. 8(22). 7 indexed citations

El‐Mallawany, Nader Kim, Lisa Giulino‐Roth, John M. Burke, Michelle L. Hermiston, & Carl E. Allen. (2023). Mature B‐cell lymphomas in adolescents and young adults. SHILAP Revista de lepidopterología. 4(4). 912–920. 2 indexed citations

Namazzi, Ruth, et al.. (2023). Safe and Effective Escalation of Evidence-Based Chemotherapy for Mature B Cell Non-Hodgkin's Lymphoma in a Low Resource Setting. Blood. 142(Supplement 1). 1753–1753.

Tomoka, Tamiwe, Ruth Namazzi, Parth S. Mehta, et al.. (2023). Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities. Pediatric Blood & Cancer. 70(5). e30242–e30242. 5 indexed citations

El‐Mallawany, Nader Kim, Sarah Alexander, Mark Fluchel, et al.. (2023). Children's Oncology Group's 2023 blueprint for research: Non‐Hodgkin lymphoma. Pediatric Blood & Cancer. 70(S6). e30565–e30565. 8 indexed citations

Milne, Paul, Harshal Abhyankar, Brooks Scull, et al.. (2022). Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAFV600E. Blood Advances. 6(16). 4901–4904. 7 indexed citations

10.

Serrallach, Bettina L., Stephen F. Kralik, Brandon Tran, et al.. (2022). Neuroimaging in Pediatric Patients with Juvenile Xanthogranuloma of the CNS. American Journal of Neuroradiology. 43(11). 1667–1673. 2 indexed citations

11.

El‐Mallawany, Nader Kim, Choladda V. Curry, & Carl E. Allen. (2021). Haemophagocytic lymphohistiocytosis and Epstein–Barr virus: a complex relationship with diverse origins, expression and outcomes. British Journal of Haematology. 196(1). 31–44. 62 indexed citations

12.

Gulati, Nitya & Carl E. Allen. (2021). Langerhans cell histiocytosis: Version 2021. Hematological Oncology. 39(S1). 15–23. 32 indexed citations

13.

Burke, Thomas M., Harshal Abhyankar, Brooks Scull, et al.. (2020). Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH. Blood. 137(13). 1777–1791. 28 indexed citations

14.

Meyer, Lauren K., Katherine Verbist, Sabrin Albeituni, et al.. (2020). JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation. Blood. 136(6). 657–668. 73 indexed citations

15.

Rodríguez‐Galindo, Carlos & Carl E. Allen. (2020). Langerhans cell histiocytosis. Blood. 135(16). 1319–1331. 168 indexed citations

16.

Rafiei, Anahita, C. Matthias Wilk, Patrick M. Helbling, et al.. (2020). BRAFV 600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell–like histiocytosis in immune-deficient mice. Blood Advances. 4(19). 4912–4917. 10 indexed citations

17.

Naik, Swati, Olive S. Eckstein, Ghadir Sasa, et al.. (2019). Incorporation of Thiotepa in a Reduced Intensity Conditioning Regimen Leads to Improved Engraftment after Stem Cell Transplant for Patients with Hemophagocytic Lymphohistiocytosis. Blood. 134(Supplement_1). 3273–3273. 1 indexed citations

18.

Teh, Bin S., et al.. (2017). Radiation Pneumonitis in Pediatric Hodgkin Lymphoma Patients receiving Radiotherapy to the Chest. International Journal of Radiation Oncology*Biology*Physics. 99(2). E569–E569. 1 indexed citations

19.

Chakraborty, Rikhia, Carl E. Allen, Amos Gaikwad, et al.. (2017). Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis. Blood. 130. 2280–2280. 1 indexed citations

20.

Allen, Carl E.. (2001). 2000 presidential address: eliminating health disparities. American Journal of Public Health. 91(7). 1142–1143. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact